Claire Swift

London, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10 publications

Tissue-Free vs Tumor-Informed ctDNA Assays for Molecular Residual Disease Detection in Early Triple Negative Breast Cancer.

Tissue-Free vs Tumor-Informed ctDNA Assays for Molecular Residual Disease Detection in Early Triple Negative Breast Cancer.

Journal: JAMA oncology

Published: August 13, 2026

Standardized Analytical Verification of ctDNA ESR1 Mutation Testing in Metastatic HR+/HER2- Breast Cancer: A European Multicentre Study Using dPCR and NGS-Based Liquid Biopsy.

Standardized Analytical Verification of ctDNA ESR1 Mutation Testing in Metastatic HR+/HER2- Breast Cancer: A European Multicentre Study Using dPCR and NGS-Based Liquid Biopsy.

Journal: Molecular diagnosis & therapy

Published: December 22, 2025

Comparison of Circulating Tumor DNA Assays for Molecular Residual Disease Detection in Early-Stage Triple-Negative Breast Cancer.

Comparison of Circulating Tumor DNA Assays for Molecular Residual Disease Detection in Early-Stage Triple-Negative Breast Cancer.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: August 11, 2023

Baseline Mutations and ctDNA Dynamics as Prognostic and Predictive Factors in ER-Positive/HER2-Negative Metastatic Breast Cancer Patients.

Baseline Mutations and ctDNA Dynamics as Prognostic and Predictive Factors in ER-Positive/HER2-Negative Metastatic Breast Cancer Patients.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: March 28, 2023

Author Correction: Genomic profile of advanced breast cancer in circulating tumor DNA.

Author Correction: Genomic profile of advanced breast cancer in circulating tumor DNA.

Journal: Nature communications

Published: July 17, 2021

Biomarkers of Response and Resistance to Palbociclib Plus Letrozole in Patients With ER+/HER2- Breast Cancer.

Biomarkers of Response and Resistance to Palbociclib Plus Letrozole in Patients With ER+/HER2- Breast Cancer.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: May 05, 2021

Genomic profile of advanced breast cancer in circulating tumour DNA.

Genomic profile of advanced breast cancer in circulating tumour DNA.

Journal: Nature communications

Published: June 29, 2020

ESR1 Mutations and Overall Survival on Fulvestrant versus Exemestane in Advanced Hormone Receptor-Positive Breast Cancer: A Combined Analysis of the Phase III SoFEA and EFECT Trials.

ESR1 Mutations and Overall Survival on Fulvestrant versus Exemestane in Advanced Hormone Receptor-Positive Breast Cancer: A Combined Analysis of the Phase III SoFEA and EFECT Trials.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: January 24, 2020

Assessment of Molecular Relapse Detection in Early-Stage Breast Cancer.

Assessment of Molecular Relapse Detection in Early-Stage Breast Cancer.

Journal: JAMA oncology

Published: August 02, 2019

Microscopic gastrointestinal stromal tumours: a clinical and molecular study of 13 cases.

Microscopic gastrointestinal stromal tumours: a clinical and molecular study of 13 cases.

Journal: Histopathology

Published: May 16, 2016

Showing 1-10 of 10

Last Updated: 09/26/2026